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Abstract
Background: Newer techniques are required to identify atherosclerotic lesions that are prone to rupture. Electric impedance
spectroscopy (EIS) is able to provide information about the cellular composition of biological tissue. The present study was
performed to determine the influence of inflammatory processes in type Va (lipid core, thick fibrous cap) and Vc (abundant
fibrous connective tissue while lipid is minimal or even absent) human atherosclerotic lesions on the electrical impedance of
these lesions measured by EIS.
Methods and Results: EIS was performed on 1 aortic and 3 femoral human arteries at 25 spots with visually heavy plaque
burden. Severely calcified lesions were excluded from analysis. A highly flexible micro-electrode mounted onto a balloon
catheter was placed on marked regions to measure impedance values at 100 kHz. After paraffin embedding, visible marked
cross sections (n=21) were processed. Assessment of lesion types was performed by Movats staining. Immunostaining for
CD31 (marker of neovascularisation), CD36 (scavenger cells) and MMP-3 (matrix metalloproteinase-3) was performed. The
amount of positive cells was assessed semi-quantitatively. 15 type Va lesions and 6 type Vc lesions were identified. Lesions
containing abundant CD36-, CD31- and MMP-3-positive staining revealed significantly higher impedance values compared
to lesions with marginal or without positive staining (CD36+455650 V vs. CD36- 346653 V, p=0.001; CD31+436643 V vs.
CD31- 340655 V, p=0.001; MMP-3+ 400668 V vs. MMP-3- 323633 V, p=0.03).
Conclusions: Atherosclerotic lesions with abundant neovascularisation (CD31), many scavenger receptor class B expressing
cells (CD36) or high amount of MMP-3 immunoreactivity reveal significantly higher impedance values compared to lesions
with marginal or no detection of immunoreactivity. Findings suggest that inflammatory processes in vulnerable plaques
affect the impedance of atherosclerotic lesions and might therefore be detected by EIS.
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Introduction
Atherosclerosis is an inflammatory disease, complicated by
progressively increasing atherosclerotic plaques that eventually
mayrupture.Plaquerupturewithsubsequentthrombusformationis
a major cause of serious cardiovascular events, such as unstable
angina, myocardial infarction and stroke [1].
The morphologic and cellular composition of the atherosclerotic
plaque is the major determinant of plaque vulnerability. Therefore,
more elaborate or adjunct complementary techniques might be
necessarytoallowdiscriminationofplaquecomponents.Ithasbeen
demonstrated earlier that electric impedance spectroscopy (EIS),
performed by a microelectrode-system mounted on a conventional
balloon catheter, has the potential to discriminate between early
stages of atherosclerosis and unaltered arteries and is able to detect
neointimalproliferationafterstentimplantation[2,3].Additionally,
EISseemstobeabletodiscriminatedifferentplaquetypesinhuman
aortic and femoral tissue [4].
The purpose of the present experimental study was to determine
the influence of inflammatory plaque components on the electric
impedance of potentially vulnerable atherosclerotic type Va (lipid
core,thickfibrouscap)andVclesions(fibrouscomplexlesions,lipid






microfabrication of the electrode structure photolithographic
methods based on semiconductor technology were used. A linear
array offour microelectrodes,transmission lines and terminals were
integrated in an insulated polyimide of 10 mm thickness. The
process technology for a polyimide-based electrode structure was
described in detail by Stieglitz et al. [6] The electrode structure
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axially with a diameter of 100 mm and a spacing of 333 mm apart.
The terminals of the electrodes were connected to a computer-
controlled impedance measurement system. The impedance
measurement system consisted of an impedance analyser SI 1260
(Solartron,Farnborough,UK)incombinationwithabioimpedance
interface SI 1294 (Solartron, Farnborough, UK). A sinusoidal
currentwasfedviatwoouterelectrodesandcontrolledinawaythat
the voltage drop across the inner electrodes was 10 mV. For all
measurementsthemagnitudeandthephaseangleoftheimpedance
were determined. Before measuring, the electrode was calibrated in
saline solution (0.9%) of known electrical conductivity.
Sample processing
1 aortic and 3 femoral human arteries were obtained during
surgicalprocedures. Thestudydesigncomplieswiththedeclaration
of Helsinki and was approved by the ethics committee of the faculty
of medicine (Mannheim, Germany). Written informed consent was
obtained from all patients. Arteries were promptly stored in 0.9%
saline solution at 4uC.
After cutting the arteries lengthwise, measuring points were
marked withadventitial crossesof threads.Segments were arranged
flat on a teflon holder to minimize the influence of different vessel
thicknesses on the electric impedance measurements [7]. Segments
werecoveredwith0.9%salinesolutionwithaleveljustashighasthe
vessel wall leading to an adsorption of the electrode on the intima of
the vessel wall. Thereafter, EIS was performed on 25 marked spots
with heavy plaque burden. Impedance measurements were
performed at 100 kHz and 37uC temperature. Obviously calcified
regions were not examined. The experimental setup of the
impedance measurement system is depicted in figure 1.
Immunostaining
Each artery segment was fixed by paraformaldehyde (4%)
immediately after the impedance measurements and was processed
for routine paraffin embedding. Cross sections of 4 mm were cut on
a kryostat and stained with haematoxylin-eosin. Out of all 25 cross
sections, 4 (16%) displayed no labelling or the labelling affected the
medial or the intimal vessel wall. Only correctly labelled cross
sections (n=21, 84%) were used for histological analysis. Movats
pentachrom staining was performed to grade lesions according to
the Stary classification of atherosclerotic lesions [5].
Histomorphological classification was conducted without knowl-
edgeoftheimpedanceresults.TypeVa(lipidcore,thickfibrouscap)
andtypeVclesions(abundantfibrousconnectivetissue,whilelipidis
minimal or even absent) were analyzed. Immunostaining was
performed using antibodies directed against CD31 (marker of
neovascularisation), CD36 (scavenger receptor class B) and MMP-3
(matrix metalloproteinase-3). The amount of positive cells was
assessed semi-quantitatively (no/minor vs. abundant staining).
Statistical analysis
Results are presented as mean6standard deviation (SD).
Comparisons of continuous variables were performed by using
Levene statistic and 2-tailed Student’s t-test. Categorical variables
were compared using the fisher’s exact test. P-values ,0.05 were
considered to be statistically significant. Vertical box plots were
drawn of numerical data. Receiver-operating characteristic (ROC)
curves were performed to estimate the test quality by assessing
sensitivity and specificity values. Cut-off values were computed
according to maximum sum of sensitivity and specificity estimates
(Youden index). For data storage and analysis, SPSS version 11.5.1
(SPSS, Inc., Chicago, Illinois) was used.
Results
In the present study, 15(71%) type Va lesions (Figure 2) and 6
(29%) type Vc lesions (Figure 3) were examined by EIS and by
histology.
Figure 1. Experimental setup of the impedance measurement system.
doi:10.1371/journal.pone.0035405.g001
Figure 2. Cross section depicting an advanced lesion type Va.
Movats staining, magnification 206. LC: Characteristic lipid core. FC:
Thick fibrous cap with yellow staining of collagen fibers and red-colored
smooth muscle cells. M: Media. Arrow: Microhemorrhages, typically
found at the lateral margin of the lipid core (red: stained fibrin).
doi:10.1371/journal.pone.0035405.g002
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When performing EIS, type Va lesions revealed a trend to
higher mean impedance values at 100 kHz compared to Vc
lesions (Va 384669 V vs. Vc 325642 V, p=0.069). After
immunostaining, type Va lesions displayed significantly more
MMP-3 staining compared to Vc lesions (p=0.046). Both lesion
types exhibited comparable amounts of CD31- and of CD36-
posititive staining (p=ns).
Impedance and inflammation
Type Va/c lesions containing abundant CD31 as well as
scavenger receptor class B expressing cells (CD36) or a high
amount of MMP-3 immunoreactivity revealed significantly higher
impedance values compared to lesions without or with marginal
staining (CD36+(n=4) 455650 V vs. CD36-(n=17) 346653 V,
p=0.001; CD31+(n=6) 436643 V vs. CD31-(n=15) 340655 V,
p=0.001; MMP-3+(n=12) 400668 V vs. MMP-3-(n=9)
323633 V, p=0.03). (Figure 4)
Computing ROC curves, the area under the curve (AUC) was
high for all markers with the highest AUC being determined for
lesions with abundant CD36 staining (0.926 (p=0.009) for
CD36+lesions; 0.900 (p=0.005) for CD31+staining; 0.843
(p=0.009) for MMP3 staining). (Figure 5)
A cut-off value of 382 V displayed a sensitivity of 100% and
a specificity of 76% for the detection of abundant CD36-positive
lesions. Values above 382 V were observed in 8 (38%) of all
lesions. A cut-off value of 361 V displayed a sensitivity of 100%
and a specificity of 80% for the detection of abundant CD31-
positive lesions. Values above 361 V were observed in 9 (42%) of
all lesions. A cut-off value of 342 V displayed a sensitivity of 75%
and a specificity of 89% for the detection of abundant MMP-3-
positive lesions. Values above 342 V were observed in 9 (42%) of
all lesions. (Table 1)
Discussion
Main findings
In the present study, atherosclerotic lesions type Va/Vc
containing inflammatory processes identified by high amounts of
MMP-3 immunoreactivity including abundant neovascularisation
(CD31) and large amounts of CD36 scavenger receptor expressing
cells revealed significantly higher impedance values compared to
lesions either with low or without positive staining. Therefore, the
results of the present study demonstrate that not just tissue
Figure 3. Cross section depicting an advanced lesion type Vc.
Movats staining, magnification 206. No lipid core. The lesion basically
consists of fibrous connective tissue (FT) with yellow staining of
collagen fibers and red-colored smooth muscle cells. M: Media.
doi:10.1371/journal.pone.0035405.g003
Figure 4. Influence of inflammation on impedance values determined by EIS (box plots).
doi:10.1371/journal.pone.0035405.g004
Figure 5. ROC curves computed by determined impedance
values (at 100 kHz). ROC curves separating samples of abundant and
minor/no staining with good (MMP-3) to excellent (CD31, CD36)
accuracy.
doi:10.1371/journal.pone.0035405.g005
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cells and their proteolytic enzymes can influence EIS results.
Inflammation and impedance
Morbidityandmortalityfromatherosclerosisislargelyduetotype
V lesions in which disruptions of the lesion surface, hematoma or
hemorrhage and thrombotic deposits have developed [5]. Factors
thatmayplayaroleincausingorfacilitatingintimaldisruptionsand
thrombosis, thus include the presence of inflammatory cells in
lesions as well as the release of toxic substances and proteolytic
enzymes by macrophages [5]. Adventitial derived vasa vasorum
neovascularisation develops under the trigger of oxidized low-
density lipoprotein depositsinthe intima,mediated e.g. byhypoxia.
Additionally, extravasation of red blood cells from leaky neovessels
attractsmacrophages.Macrophageerythrophagocitosisleadstocell
activation at crucial sites of the plaque and macrophage-derived
MMP secretion occurs [8]. MMPs are able to directly degrade
extracellular matrix components and cleave many cell surface
moleculesandextracellularregulators.Theythereforeinfluencenot
only matrix remodelling but the migration, proliferation and death
of vascular cells [9]. It is well known that the loss of collagen and
otherextracellularmatrixcomponentsoccursinthehighly-inflamed
regionsofplaquecap,therebyreducingtensilestrength,aswellasin
the lipid core [9]. CD36 scavenger receptors, expressed on
macrophages, additionally trigger cytoskeletal remodelling, impor-
tant events in foam cell formation and macrophage migration [10].
These effects eventually lead to the rupture of the internal elastic
lamina and fibrous cap collagenolysis, precipitating plaque rupture
and thrombosis [11,12].
The above mentioned inflammatory processes of active
atherosclerotic lesions seem to have a higher impact on EIS than
the tissue structure of type Va and type Vc lesions itself as lesions
containing abundant CD31, CD36 or MMP-3 immunoreactivity
revealed significantly higher impedance values compared to lesions
without or with minor staining while the overall mean impedance
values of type Va vs. type Vc lesions did not differ significantly.
Therefore, EIS might be a feasible method to detect atheroscle-
rotic lesions containing inflammatory activity.
Experimental setup, clinical perspectives and potential
limitations of EIS
The first in vitro experimental study measuring resistance of
human atherosclerotic plaques was performed by Slager et al.
using a spot electrode in conjunction with a large plate electrode
[13]. Stiles et al. developed a computer simulation to characterize
different types of atherosclerotic lesions [14]. Two years later,
changes in the electric impedance conducted with four wire
electrodes in bovine aorta made it possible to determine the
moment when an electrode made contact with the arterial wall
[15]. Subsequently, a four-point microelectrode mounted on
a conventional coronary balloon catheter was newly designed,
enabling intravascular measurements of small vessel areas. The
performance of the balloon impedance catheter was evaluated in
an atherosclerotic rabbit model. Results indicated that aortic
segments with atherosclerotic plaques revealed different imped-
ance values compared to unaltered aortic tissue [2]. Subsequently,
neointimal growth after iliacal stent implantation was detected in
an animal model under in-vivo conditions [3]. The next step was
to examine human atherosclerotic tissue. In this setup, EIS was
able to distinguish different high grade atherosclerotic lesions from
another at 100 kHz frequency [4]. Although the limited number
of available samples might have influenced our data, the results of
the present study now demonstrate that not just plaque structure
but also qualitative components like inflammatory cells and their
proteolytic enzymes influence EIS results, representing a next step
when utilizing this new method. However, EIS has to be
performed in settings with the lowest achievable environmental
influence. It is well known from earlier experiments that EIS
requires a close tissue contact [7,16]. Vessel damage might
constitute an additional important limitation of the technique
itself. Therefore, only spots without visible damage were analyzed
in the present study and the tissue contact was kept constant.
Perspectively, more has to be learned about the in vivo application
of the device. The impact of blood stream and the electric
properties of blood surrounding the electrodes during EIS have to
be determined. The influence of the pulsatile vessel movement and
of electric currents has to be assessed. Furthermore, it has to be
evaluated if the method is as sensitive in the coronaries with
smaller vessel diameters and lower intimal thicknesses compared to
the femoral and aortic arteries under test, although simulations
performed before demonstrated that inner vessel diameters did not
influence measurement results [7]. However, along with further
knowledge and appropriate technical development, EIS could be
an additional tool to provide online in vivo information of
atherosclerotic lesions in future.
Conclusion
Atherosclerotic lesions with abundant neovascularisation
(CD31), many scavenger receptor class B expressing cells (CD36)
or high amount of MMP-3 immunoreactivity reveal significantly
higher impedance values compared to lesions with marginal or no
detection of immunoreactivity. Our findings suggest that in-
flammatory processes in vulnerable plaques affect the impedance
of atherosclerotic lesions and might therefore be detected by EIS.
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